Pre-market hot trades in US stocks: J-Star pre-market down 9.04%; Equinor Asa pre-market down 8.91%

Popular Pre-Market Trades in U.S. Stocks J-Star, down 9.04% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Equinor Asa is down 8.91% in pre-market trading. Based on recent key news: On May 6, the Norwegian National Petroleum Company announced its first-quarter results, with net profit soaring 18% year-on-year, but revenue declined, leading to market doubts about future profitability and a drop in stock price. Source: Investing.com On May 6, the CEO stated that despite the tense situation in the Middle East, it will take time for the oil market to return to normal, increasing market concerns about oil price volatility. Source: Zhitong Finance On May 6, the company announced the launch of its second phase stock repurchase plan for 2026, planning to repurchase $375 million worth of stock by the end of July, with mixed market reactions to the repurchase plan. Source: Dow Jones Newswires. Oil price volatility is intensifying, and market sentiment is cautious. Top Gainers in Pre-Market U.S. Stocks Entravision Communications is up 72.61% in pre-market trading. Based on recent key news: On May 5, Entravision released its first-quarter financial report, showing a GAAP earnings per share of $0.13 and revenue of $196.97 million, a year-on-year increase of 114.4%. This strong financial performance drove a significant rise in stock price. Source: Entravision Press Release On May 5, Entravision's first-quarter operating income was $20.689 million, with a pre-tax profit of $17.754 million and a net profit of $12.36 million. These financial figures exceeded market expectations, further boosting investor confidence. Source: Reuters On May 5, Entravision's local advertising revenue grew by 6%, while national advertising revenue fell by 18%. Despite the decline in national advertising revenue, the overall financial performance was strong, driving the stock price up. Source: Company Press Release. The advertising industry is facing structural adjustments and requires attention. Yidianxing is up 67.37% in pre-market trading, with no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Avalo Therapeutics is up 50.40% in pre-market trading. Based on recent key news: On May 6, Avalo Therapeutics announced that its LOTUS trial successfully reached the primary endpoint at both doses studied. This positive clinical trial result drove the stock price up. On May 5, Avalo Therapeutics announced a public offering of $375 million at a price of $17.75 per share. This move increased market confidence in the company's future development, further driving the stock price up On May 6th, Avalo Therapeutics' stock rose 48.5% in after-hours trading, reflecting a positive market response to the company's recent announcements. There is an increased interest in biotech stocks, with a noticeable inflow of funds